DEXWireNews

RISKY AVDL LOOKS TASTY R:R IS SAVAGE

Long
NASDAQ:AVDL   Avadel Pharmaceuticals plc
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.

SHORT INTEREST
6.53M 07/31/19

P/E Current
-0.85

P/E Ratio (with extraordinary items)
-0.80

Average Recommendation: BUY

Average Target Price: 4.50

⭐⭐⭐ Sign Up for Free ⭐⭐⭐

1) Download our App on Google Play! dexwirenews.com/APP

2) Text Message Notifications: dexwirenews.com/SMS

3) Telegram: t.me/DEXWireNews

4) Follow Us on our Social Networks
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.